Stock Market News, July 10, 2025: S&P Hits New Record; Treasury Yields Rise
Trump’s tariffs and the trade war continue to affect global markets. Follow along for live updates on the Dow, S&P 500 and Nasdaq.
European stocks brush off Trump’s copper, pharma tariff threats
European stock markets rose Wednesday, brushing off US President Donald Trump’s tariff threats on copper and pharmaceuticals.
BorgWarner Inc. stock underperforms Monday when compared to competitors
This was the stock’s second consecutive day of losses.
Artelo Biosciences Stock Soars 114% After Promising Depression Treatment Data
Artelo Biosciences Inc (NASDAQ:ARTL) shares surged 114.2% following the presentation of encouraging preclinical data for its CBD and TMP cocrystal drug candidate, ART12.11, at the 35th Annual …
As US stocks hit records, experts see the dollar falling further
While the US stock market has fully recovered from a spring rout, the relentless drop in the dollar is prompting currency experts to warn of greater financial market turmoil ahead.
CBD Stocks Creating Opportunities – Established (BCCI), (STG), (WEED), (ACRGF), (RLTR), (CBMJ), and Newcomer (VAPR) Lead the Charge
You would have to be living in isolation to have not picked up on the hottest marijuana derivative consumable and therapeutic center isolate CBD. CBD “Cannabidiol” is the non-psychoactive full spectrum derivative of the hemp and marijuana plant largely credited for the majority of the medical beneficial attributes associated with marijuana.
2 Stocks Down More Than 90% That Still Aren’t Worth Buying
Now, it’s worth noting Stock Advisor’s total average return is 1,060% — a market-crushing outperformance compared to 182% for the S&P 500. Don’t miss out on the latest top 10 list, available when you …
Neural Therapeutics Acquires Stake in German CBD Retailer Hanf.com
An announcement from Neural Therapeutics Inc. ( ($TSE:NURL) ) is now available. Neural Therapeutics Inc. has completed the acquisition of a 30.75% …
CenTex CBD is closing their doors amidst uncertainty and political debate
The ongoing battle to ban THC in Texas led to their decision.
Cardiol Therapeutics’ stock down 20% on Phase II CardiolRx failure
CardiolRx did not have a significant impact on left ventricular extracellular volume (LV-ECV) in the Phase II ARCHER study.
American Tower REIT stock outperforms competitors despite losses on the day
Shares of American Tower REIT AMT slid 1.23% to $217.52 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.80% to 6,141.02 …
Canadian Pacific Kansas City Ltd. stock rises Thursday, outperforms market
Shares of Canadian Pacific Kansas City Ltd. CP inched 0.79% higher to C$107.77 Thursday, in what proved to be an all-around positive trading session for the Canadian market, with the S&P/TSX Composite …
What’s Going On With Tilray Brands Stock Today?
According to Benzinga Pro, TLRY stock has lost over 76% in the past year. In a separate release, Montauk Brewing Co., a Tilray Brands company, announced a limited-edition collaboration with lifestyle …
Kinross Gold Corp. stock rises Wednesday, outperforms market
Shares of Kinross Gold Corp. K inched 0.19% higher to C$21.02 Wednesday, in what proved to be an otherwise all-around poor trading session for the Canadian market, with the S&P/TSX Composite Index …
Tilray Makes History, First To Import And Sell Branded Medical Cannabis In Italy
Through its wholly-owned subsidiary, FL Group, Tilray has become the first company in Italy to receive official authorization from the Ministero della Salute (Italian Ministry of Health) to import and …
Recent Comments